MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
3. Government ... Funders, Regulators, Policy Makers, Conveners
*Government: International
Europe
*Europe: Regions
*Western Europe
Ireland
*Industry: Ireland
Charles River Laboratories International, Inc. (NYSE:CRL)*
Organization & Developments: Charles River Labs
Parents
Charles River Laboratories International, Inc. (NYSE:CRL)*
Children
*Charles River Laboratories is a global provider of solutions that advance the drug discovery and development process.
*Charles River Laboratories is the largest laboratory animal production company in the world, and also offers a number of preclinical and clinical support capabilities.
*Mice breeding facility at Fort Detrick
*PROVIDES OUTSOURCED PRECLINICAL AND PHASE I SERVICES, ANIMALRESEARCH MODELS AND ASSOCIATED SERVICES.
# Customers: Leading pharmaceutical, biotechnology, government, and academic organizations around the world
# Global presence: 70 facilities in 18 countries
# Ownership: Publicly traded
# Revenue: $1.2 billion in FY2009
2014: The two companies being acquired perform so-called in vitro testing, the kind that new drugs undergo before animal testing even begins. CRL, on the other hand, is overwhelmingly geared toward animal-based testing of drugs
2014: What Charles River Labs' recent buys say about the future of biotech
2020: Charles River Laboratories and Deciphex Form a Partnership to Enhance Drug Discovery & Development With Digital Pathology
2021: Charles River Laboratories: Expensive, But Will It Ever Get Cheap?
2022: Charles River Laboratories International, Inc. 2022 Q3 - Results - Earnings Call Presentation_ seekingalpha.com
2022: Charles River Laboratories: A 'Picks And Shovels' Biomedical Play, Now Attractively Priced_seekingalpha.com
2022: Charles River Laboratories: Price Discovery_ seekingalpha.com
2023: Diving Into The Lab (Rating Upgrade) (NYSE:CRL)
2024: Charles River Laboratories expands incubator to discovery-stage biotechs
2024: Charles River Laboratories: Business Model, SWOT Analysis, and Competitors 2024
2024: Charles River Laboratories: Changing Economics Reduces Compounding Ability (Rating Downgrade)_seekingalpha.com
2024: Charles River Laboratories: Not The Right Time To Own At This Point In The Cycle
2024: Charles River Laboratories: Q2, Cost Structure Streamlining (Rating Upgrade)
2024: Charles River Labs closes several locations, 1,300+ jobs cut in cost saving initiative
2024: Decoding Charles River Laboratories International Inc (CRL): A Strategic SWOT Insight
Jumps
*Key People: Charles River Labs
Finance & Acquisitions: Charles River Labs